Drug Firm Lupin received USFDA approval to market HIV drug Prezista tablets

Dec 31, 2014, 16:41 IST

The tablets with chemical name Darunavir Ethanolate will be used to treat HIV-1 infection.

Drug firm Lupin on 30 December 2014 received the approval from the United States Food and Drugs Administration (USFDA) to market its generic drug Prezista tablets in the US. The tablets with chemical name Darunavir Ethanolate will be used to treat HIV-1 infection.

Earlier, the company had also received USFDA approval to market a generic version of ViiV Healthcare’s Epivir Tablets, used in treating HIV infection, in the American market.

About Lupin

The company is headquartered in Mumbai, India. Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations for the developed and developing markets of the world.

Jagranjosh
Jagranjosh

Education Desk

Your career begins here! At Jagranjosh.com, our vision is to enable the youth to make informed life decisions, and our mission is to create credible and actionable content that answers questions or solves problems for India’s share of Next Billion Users. As India’s leading education and career guidance platform, we connect the dots for students, guiding them through every step of their journey—from excelling in school exams, board exams, and entrance tests to securing competitive jobs and building essential skills for their profession. With our deep expertise in exams and education, along with accurate information, expert insights, and interactive tools, we bridge the gap between education and opportunity, empowering students to confidently achieve their goals.

... Read More
Get here latest daily, weekly and monthly Current Affairs and GK in English and Hindi for UPSC, SSC, Banking, Railway, Defence and exams. Download Jagran Josh Current Affairs App.

Take Weekly Tests on app for exam prep and compete with others. Download Current Affairs and GK app

AndroidIOS

Trending

Latest Education News